Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

Michael Pazianas1 The Botnar Research Centre and Oxford University Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases, Nuffield Orthopaedic Centre, Headington, Oxford, UKCorrespondence[email protected] [email protected]

Cyrus Cooper1 The Botnar Research Centre and Oxford University Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases, Nuffield Orthopaedic Centre, Headington, Oxford, UK;2 MRC Epidemiology Resource Centre, University of Southampton, Southampton General Hospital, Southampton, UK

F Hal Ebetino3 Warner Chilcott, New Jersey, USA

R Graham G Russell1 The Botnar Research Centre and Oxford University Institute of Musculoskeletal Sciences, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Diseases, Nuffield Orthopaedic Centre, Headington, Oxford, UK;4 The Mellanby Centre for Bone Research, Department of Human Metabolism, Sheffield University Medical School, Sheffield, UKCorrespondence[email protected] [email protected]

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis

Figures & data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date